Arcutis Biotherapeutics Inc. (ARQT) PT Lowered to $35 at Morgan Stanley
Tweet Send to a Friend
Morgan Stanley analyst David Lebowitz ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
